Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company.
Several brokerages have commented on STVN. Morgan Stanley reiterated an “equal weight” rating and set a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. William Blair reiterated an “outperform” rating on shares of Stevanato Group in a report on Friday, March 7th. Wolfe Research initiated coverage on shares of Stevanato Group in a report on Friday, December 13th. They set an “outperform” rating and a $28.00 price target for the company. UBS Group dropped their price objective on Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a research note on Friday, March 7th. Finally, Bank of America raised their target price on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th.
View Our Latest Stock Analysis on STVN
Hedge Funds Weigh In On Stevanato Group
Stevanato Group Stock Down 3.4 %
Stevanato Group stock opened at €20.26 ($21.78) on Friday. The company has a market capitalization of $6.14 billion, a P/E ratio of 43.11, a P/E/G ratio of 7.18 and a beta of 0.60. Stevanato Group has a 1-year low of €16.56 ($17.81) and a 1-year high of €32.98 ($35.46). The firm’s fifty day simple moving average is €20.95 and its 200-day simple moving average is €20.59. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22.
Stevanato Group (NYSE:STVN – Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.22). The company had revenue of €352.68 million during the quarter, compared to analysts’ expectations of €346.26 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Sell-side analysts forecast that Stevanato Group will post 0.5 earnings per share for the current fiscal year.
Stevanato Group Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Read More
- Five stocks we like better than Stevanato Group
- What Are Earnings Reports?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- What is a SEC Filing?
- Top 3 Beverage Stocks Pouring Out Profits
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.